loadpatents
Patent applications and USPTO patent grants for GONZALEZ LOPEZ DE TURISO; Felix.The latest application filed is for "bisamide sarcomere activating compounds and uses thereof".
Patent | Date |
---|---|
Bisamide Sarcomere Activating Compounds And Uses Thereof App 20220281850 - ASHCRAFT; Luke ;   et al. | 2022-09-08 |
CIS-morpholinone and other compounds as MDM2 inhibitors for the treatment of cancer Grant 11,407,721 - Bartberger , et al. August 9, 2 | 2022-08-09 |
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer App 20220169611 - Bartberger; Michael D. ;   et al. | 2022-06-02 |
Compounds that inhibit MCL-1 protein Grant 11,306,107 - Brown , et al. April 19, 2 | 2022-04-19 |
Bisamide sarcomere activating compounds and uses thereof Grant 11,299,479 - Ashcraft , et al. April 12, 2 | 2022-04-12 |
ASK1 inhibiting agents Grant 11,168,095 - Gonzalez Lopez de Turiso , et al. November 9, 2 | 2021-11-09 |
Ask1 Inhibiting Agents App 20210317103 - Gonzalez Lopez de Turiso; Felix ;   et al. | 2021-10-14 |
Pyridine Macrocycle Compounds As Ask1 Inhibiting Agents App 20210300946 - Gonzalez Lopez de Turiso; Felix | 2021-09-30 |
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer App 20210179560 - Bartberger; Michael D. ;   et al. | 2021-06-17 |
Ask1 Inhibiting Agents App 20210115020 - Gonzalez Lopez de Turiso; Felix ;   et al. | 2021-04-22 |
Bisamide sarcomere activating compounds and uses thereof Grant 10,899,746 - Ashcraft , et al. January 26, 2 | 2021-01-26 |
Bisamide Sarcomere Activating Compounds And Uses Thereof App 20200223829 - Ashcraft; Luke ;   et al. | 2020-07-16 |
Bisamide Sarcomere Activating Compounds And Uses Thereof App 20200223830 - Ashcraft; Luke ;   et al. | 2020-07-16 |
Heterocyclic Compounds And Their Uses App 20200048265 - CHEN; Yi ;   et al. | 2020-02-13 |
Ask1 Inhibiting Agents App 20190359634 - Gonzalez Lopez de Turiso; Felix ;   et al. | 2019-11-28 |
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer App 20190062276 - Bartberger; Michael D. ;   et al. | 2019-02-28 |
Cis-morpholinone And Other Compounds As Mdm2 Inhibitors For The Treatment Of Cancer App 20180354918 - BARTBERGER; Michael D. ;   et al. | 2018-12-13 |
Heterocyclic Compounds And Their Uses App 20180105532 - CHEN; Yi ;   et al. | 2018-04-19 |
Heterocyclic compounds and their uses Grant 9,873,701 - Chen , et al. January 23, 2 | 2018-01-23 |
Heterocyclic compounds and their uses Grant 9,873,704 - Bui , et al. January 23, 2 | 2018-01-23 |
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer App 20170144971 - BARTBERGER; Michael D. ;   et al. | 2017-05-25 |
Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer Grant 9,593,129 - Bartberger , et al. March 14, 2 | 2017-03-14 |
Heterocyclic Compounds And Their Uses App 20160333017 - BUI; Minna ;   et al. | 2016-11-17 |
Heterocyclic compounds as MDM2 inhibitors for the treatment of cancer Grant 9,376,425 - Bartberger , et al. June 28, 2 | 2016-06-28 |
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer App 20160137667 - BARTBERGER; Michael D. ;   et al. | 2016-05-19 |
Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer Grant 9,296,736 - Bartberger , et al. March 29, 2 | 2016-03-29 |
Cis-morpholinone And Other Compounds As Mdm2 Inhibitors For The Treatment Of Cancer App 20160002185 - BARTBERGER; Michael D. ;   et al. | 2016-01-07 |
Heterocyclic Compounds And Their Uses App 20150045361 - CHEN; Yi ;   et al. | 2015-02-12 |
Quinoline derivitives and their uses Grant 8,940,724 - Cushing , et al. January 27, 2 | 2015-01-27 |
Heterocyclic compounds and their uses Grant 8,901,135 - Chen , et al. December 2, 2 | 2014-12-02 |
Piperidinone Derivatives As Mdm2 Inhibitors For The Treatment Of Cancer App 20140315895 - Bartberger; Michael D. ;   et al. | 2014-10-23 |
Heterocyclic compounds and their uses Grant 8,835,432 - Bui , et al. September 16, 2 | 2014-09-16 |
Heterocyclic Compounds As Mdm2 Inhibitors For The Treatment Of Cancer App 20140235629 - Bartberger; Michael D. ;   et al. | 2014-08-21 |
Heterocyclic Compounds And Their Uses App 20140206694 - Bui; Minna ;   et al. | 2014-07-24 |
Tricyclic inhibitors of hydroxysteroid dehydrogenases Grant 8,765,788 - Powers , et al. July 1, 2 | 2014-07-01 |
Heterocyclic compounds and their uses Grant 8,765,940 - Brown , et al. July 1, 2 | 2014-07-01 |
Heterocyclic compounds and their uses Grant 8,716,290 - Bui , et al. May 6, 2 | 2014-05-06 |
Heterocyclic compounds and their uses Grant 8,633,313 - Cushing , et al. January 21, 2 | 2014-01-21 |
Piperidinone Derivatives As Mdm2 Inhibitors For The Treatment Of Cancer App 20140011796 - BARTBERGER; Michael David ;   et al. | 2014-01-09 |
Heterocyclic compounds and their uses Grant 8,586,739 - Chen , et al. November 19, 2 | 2013-11-19 |
Heterocyclic Compounds And Their Uses App 20130267526 - Chen; Yi ;   et al. | 2013-10-10 |
Heterocyclic Compounds And Their Uses App 20130267524 - Bui; Minna ;   et al. | 2013-10-10 |
Heterocyclic Compounds And Their Uses App 20130090323 - Dransfield; Paul John ;   et al. | 2013-04-11 |
Heterocyclic Compounds And Their Uses App 20130079342 - Dransfield; Paul John ;   et al. | 2013-03-28 |
Heterocyclic Compounds And Their Uses App 20120220586 - Chen; Yi ;   et al. | 2012-08-30 |
Heterocyclic Compounds And Their Uses App 20120094972 - Brown; Matthew ;   et al. | 2012-04-19 |
Piperidinone Derivatives As Mdm2 Inhibitors For The Treatment Of Cancer App 20110319378 - BARTBERGER; Michael David ;   et al. | 2011-12-29 |
Heterocyclic Compounds And Their Uses App 20110152296 - Cushing; Timothy D. ;   et al. | 2011-06-23 |
Heterocyclic Compounds And Their Uses App 20100331293 - Cushing; Timothy D. ;   et al. | 2010-12-30 |
Heterocyclic Compounds And Their Uses App 20100331306 - Bui; Minna ;   et al. | 2010-12-30 |
Tricyclic Inhibitors Of Hydroxysteroid Dehydrogenases App 20100280073 - Powers; Jay P. ;   et al. | 2010-11-04 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.